分子量: 28443.596 Da / 分子数: 1 / 変異: N-TERMINAL HIS-TAGGED / 由来タイプ: 組換発現 由来: (組換発現) Rous sarcoma virus (ラウス肉腫ウイルス) 属: Alpharetrovirus / 株: SCHMIDT RUPPIN A-2 解説: THE SOURCE OF THE CA_RSV GENE IS PLASMID PSRA-2 OF ATCC 45000, WHICH IS A PLASMID CLONE CONTAINING FULL LENGTH ROUS SARCOMA VIRUS, STRAIN SCHMIDT RUPPIN A-2, DERIVED FROM UNINTEGRATED DNA ...解説: THE SOURCE OF THE CA_RSV GENE IS PLASMID PSRA-2 OF ATCC 45000, WHICH IS A PLASMID CLONE CONTAINING FULL LENGTH ROUS SARCOMA VIRUS, STRAIN SCHMIDT RUPPIN A-2, DERIVED FROM UNINTEGRATED DNA FROM AN ACUTE INFECTION OF QT-6 CELLS プラスミド: PET-16B (NOVAGEN) / 発現宿主: Escherichia coli (大腸菌) / 株 (発現宿主): HMS174(DE3) PLYSS / 参照: UniProt: O92954
-
実験情報
-
実験
実験
手法: 溶液NMR
NMR実験
Conditions-ID
Experiment-ID
Solution-ID
タイプ
1
1
1
4D 13C-SEPARATED NOESY
1
2
1
4D 13C/15N-SEPARATED NOESY
1
3
1
4D 15N-SEPARATED NOESY
1
4
1
3D 15N- SEPARATED NOESY
NMR実験の詳細
Text: THE 1H, 13C, AND 15N CHEMICAL SHIFT ASSIGNMENTS HAVE BEEN DEPOSITED ATTHE BIOMOLECULAR RESONANCE DATABANK (BMRB ENTRY 4384).
-
試料調製
詳細
Solution-ID
内容
溶媒系
1
~1 MM CA_RSV, 10 MM PHOSPHATE (PH 6.0), 0.2 MM N3NA, 0.1 MM EDTA, 0.1 MM PMSF, 1 MG/L PEPSTATIN A, 5 MM BETA-MERCAPTOETHANOL
90% H2O/10% D2O
2
~1 MM CA_RSV, 10 MM PHOSPHATE (PH 6.0), 0.2 MM N3NA, 0.1 MM EDTA, 0.1 MM PMSF, 1 MG/L PEPSTATIN A, 5 MM BETA-MERCAPTOETHANOL
100% D2O
試料状態
イオン強度: 10 mM PHOSPHATE / pH: 6 / 圧: 1 atm / 温度: 303.00 K
結晶化
*PLUS
手法: other / 詳細: NMR
-
NMR測定
NMRスペクトロメーター
タイプ: Bruker DRX / 製造業者: Bruker / モデル: DRX / 磁場強度: 800 MHz
-
解析
NMR software
名称
バージョン
開発者
分類
DYANA
1.5
P.GUNTHER, ETH-ZURICH
精密化
XwinNMR
2.5
構造決定
NMRPipe
1999
構造決定
NMRView
3
構造決定
TALOS
1999.019.15.47
構造決定
精密化
手法: TORSION ANGLE DYNAMICS SIMULATED ANNEALING / ソフトェア番号: 1 詳細: 20 CONFORMERS COMPATIBLE WITH THE NMR CONSTRAINTS WERE CALCULATED USING DYANA 1.5 AND THE STANDARD TORSION ANGLE SIMULATED ANHEALING PROTOCOL. PRELIMINARY CALCULATIONS WERE CARRIED OUT ...詳細: 20 CONFORMERS COMPATIBLE WITH THE NMR CONSTRAINTS WERE CALCULATED USING DYANA 1.5 AND THE STANDARD TORSION ANGLE SIMULATED ANHEALING PROTOCOL. PRELIMINARY CALCULATIONS WERE CARRIED OUT INDEPENDENTLY FOR EACH OF THE TWO N- AND C- TERMINAL DOMAINS OF THE PROTEIN. INITIALLY ONLY NOE DISTANCE CONSTRAINTS WERE IMPOSED. THE INITIAL STRUCTURES WERE THEN USED TO ASSES THE ACCURACY OF THE TORSION ANGLE CONSTRAINTS GENERATED BY ANALYSIS OF HA, CA, CB, CO AND N CHEMICAL SHIFTS WITH THE PROGRAM TALOS. FINALLY, UPPER AND LOWER LIMIT DISTANCE CONSTRAINTS WERE IMPOSED FOR UNAMBIGUOUS INTRAHELICAL H-BONDS.
NMRアンサンブル
コンフォーマー選択の基準: target function / 計算したコンフォーマーの数: 20 / 登録したコンフォーマーの数: 20